Royal Sense Limited Unveils 'Stergic Pharmacy' Franchise Model, Targets Nationwide Expansion

Royal Sense Limited has announced the launch of its new franchise business model, 'Stergic Pharmacy', marking a significant step in the company's growth strategy. The initiative, revealed in a regulatory filing dated August 12, 2025, aims to establish a network of franchise-owned and company-operated (FOCO) retail stores across India.

Franchise Model Details

The 'Stergic Pharmacy' concept is designed to offer over 500 products through franchise-based retail outlets. This move represents Royal Sense's strategic approach to expand its presence in the pharmaceutical retail sector while leveraging the local expertise of franchise partners.

Strong Initial Interest

According to the company's disclosure, the launch has already garnered substantial interest from potential franchisees. Royal Sense has received more than 125 franchise applications, highlighting the attractiveness of the business model. The company is currently evaluating these applications to select candidates who align best with its strategic objectives and quality standards.

Management's Perspective

Rishabh Arora, Managing Director of Royal Sense Limited, signed the regulatory filing, underscoring the importance of this initiative. The company views the 'Stergic Pharmacy' franchise model as a significant growth opportunity, potentially accelerating its expansion in the competitive pharmaceutical retail market.

Future Outlook

Royal Sense Limited has committed to providing updates to the stock exchanges and stakeholders as further developments occur. The company's focus on careful selection of franchise partners suggests a strategic approach to ensure the quality and consistency of the 'Stergic Pharmacy' brand across various locations.

This new venture represents a notable development in the Indian pharmaceutical retail landscape, potentially offering investors and stakeholders a new avenue for growth. As Royal Sense progresses with its franchise model, market observers will be keen to see how it impacts the company's market position and financial performance in the coming quarters.